Company news
Transmedics Group, Inc. (NASDAQ:TMDX) news
Transmedics Group, Inc. news releases on 6ix. Latest, Nov 6, 2023: TransMedics Reports Third Quarter 2023 Financial Results
Press releases — page 2
TransMedics Reports Third Quarter 2023 Financial Results
November 5, 2023
TransMedics to Report Third Quarter 2023 Financial Results on November 6, 2023
October 22, 2023
TransMedics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
August 27, 2023
TransMedics Completes Acquisition of Summit Aviation
August 15, 2023
TransMedics Reports Second Quarter 2023 Financial Results
August 2, 2023
TransMedics Acquires Warm Perfusion EVOSS™ and Cold Perfusion LifeCradle® Technologies from Bridge to Life
August 1, 2023
TransMedics Signs Definitive Agreement to Acquire Summit Aviation to Expand TransMedics Aviation Capabilities for Organ Transplantation
July 31, 2023
TransMedics to Present at the Canaccord Genuity 43rd Annual Growth Conference
July 25, 2023
TransMedics Appoints Anil Ranganath as Senior Vice President, General Counsel and Corporate Secretary
July 25, 2023
TransMedics to Report Second Quarter 2023 Financial Results on August 3, 2023
July 19, 2023
TransMedics Group, Inc. Prices $400 Million of Convertible Senior Notes Due 2028
May 7, 2023
TransMedics Group, Inc. Announces Proposed Offering of $300 Million of Convertible Senior Notes Due 2028
May 7, 2023
TransMedics Reports First Quarter 2023 Financial Results
April 30, 2023
TransMedics Releases Inaugural Environmental, Social & Governance (ESG) Report
April 30, 2023
TransMedics to Report First Quarter 2023 Financial Results on May 1, 2023
April 16, 2023
TransMedics Reports Fourth Quarter and Full Year 2022 Financial Results
February 21, 2023
TransMedics to Report Fourth Quarter and Full Year 2022 Financial Results on February 22, 2023
February 7, 2023
TransMedics Appoints Nick Corcoran as Senior Vice President of Supply Chain and Operations
February 1, 2023
TransMedics to Participate in the 41st Annual J.P. Morgan Healthcare Conference
December 20, 2022
TransMedics Reports Third Quarter 2022 Financial Results
November 2, 2022
TransMedics to Report Third Quarter 2022 Financial Results on November 3, 2022
October 19, 2022
TransMedics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
August 28, 2022
TransMedics Announces Upsize and Pricing of Public Offering of Common Stock
August 3, 2022
TransMedics Announces Proposed Public Offering of Common Stock
August 2, 2022
TransMedics Reports Second Quarter 2022 Financial Results
July 31, 2022
TransMedics to Present at the Canaccord Genuity 42nd Annual Growth Conference
July 25, 2022
TransMedics to Report Second Quarter 2022 Financial Results on August 1, 2022
July 17, 2022
TransMedics Reports First Quarter 2022 Financial Results
May 2, 2022
TransMedics Receives FDA PMA Approval of OCS™ DCD Heart Indication
April 27, 2022
TransMedics to Report First Quarter 2022 Financial Results on May 3, 2022
April 18, 2022
TransMedics Announces the Presentation of New OCS™ Heart and OCS™ Lung Clinical Data at the International Society of Heart and Lung Transplantation 2022 Annual Meeting
April 18, 2022
TransMedics to Present at the Oppenheimer's 32nd Annual Healthcare Conference
February 28, 2022
TransMedics Reports Fourth Quarter and Full Year 2021 Financial Results
February 22, 2022
TransMedics to Present at the Cowen 42nd Annual Healthcare Conference
February 21, 2022
TransMedics to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022
February 8, 2022
TransMedics Announces Publication of OCS™ Liver PROTECT Trial Results in JAMA Surgery
January 4, 2022
TransMedics to Present at the 40th Annual J.P. Morgan Healthcare Conference
December 21, 2021
TransMedics Reports Third Quarter 2021 Financial Results
November 8, 2021
TransMedics to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics, and Digital Health & Services Forum
November 3, 2021
TransMedics Announces Positive Top Line Results From the U.S. Randomized OCS DCD Heart Trial
November 3, 2021
TransMedics to Report Third Quarter 2021 Financial Results on November 9, 2021
October 25, 2021
TransMedics Receives FDA Approval for its OCS Liver System for Preservation and Assessment of Donor Livers for Transplantation
September 28, 2021
TransMedics Receives FDA Approval for its OCS Heart System Enabling Broader Utilization of Donor Hearts for Transplantation in the U.S.
September 6, 2021
TransMedics to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
August 25, 2021
TransMedics Reports Second Quarter 2021 Financial Results
August 4, 2021
TransMedics Receives FDA Clearance of OCS Lung Solution for Cold Preservation of Lungs
July 28, 2021
TransMedics to Participate in the Canaccord Genuity 41st Annual Growth Conference
July 27, 2021
TransMedics to Report Second Quarter 2021 Financial Results on August 5, 2021
July 21, 2021
TransMedics Stock Trading Halted Today; FDA Advisory Committee to Review Premarket Approval Application for the OCS Liver System
July 13, 2021
TransMedics Announces Positive FDA Advisory Committee Vote for the OCS Liver System
July 13, 2021